Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPDE-PAULA, Vanessa J.SANTOS, Carla Cristine C. dosLUQUE, Maria Carolina A.ALI, Taccyana M.KALIL, Jorge E.FORLENZA, Orestes V.CUNHA-NETO, Edecio2021-02-182021-02-182021METABOLIC BRAIN DISEASE, v.36, n.1, p.193-197, 20210885-7490https://observatorio.fm.usp.br/handle/OPI/39037Lithium activates Wnt/beta-catenin signaling leading to stabilization of free cytosolic beta-catenin. The aim of the present study is to evaluate the in vivo effect of acute and chronic lithium treatment on the expression of beta-catenin target genes, addressing its transcripts HIG2, Bcl-xL, Cyclin D1, c-myc, in cortical and hippocampal tissue from adult mice. Lithium doses were established to yield therapeutic working concentrations. In acute treatment, mice received a 300 mu L of a 350 mg/kg solution of LiCl by gavage, and were euthanized after 2 h, 6 h and 12 h. To determine the effect of chronic treatment, animals were continuously fed either with chow supplemented with 2 g/kg Li2CO3, or regular chow (controls), being euthanized after 30 days. All animals had access to drinking water and 0.9% saline ad libitum. After acute and chronic treatments samples of peripheral blood were obtained from the tail vein for each animal, and serum concentrations of lithium were determined. All transcripts were up-regulated in cortical and hippocampal tissues of lithium-treated mice, both under acute and chronic treatments. There was a positive correlation between serum lithium concentrations and the increment in the expression of all transcripts. This effect was observed in all time points of the acute treatment (i.e., 2, 6 and 12 hours) and also after 30 days. We conclude that Wnt/beta-catenin transcriptional response (HIG2, Bcl-xL, Cyclin D1 and c-myc) is up-regulated in the mouse brain in response to acute and chronic lithium treatment at therapeutic concentrations.engrestrictedAccessLithiumWnt/beta-cateninHIG2Bcl-xLCyclin D1c-mycbcl-xlneuronscortexneuroprotectionexpressioncellsarticleCopyright SPRINGER/PLENUM PUBLISHERS10.1007/s11011-020-00638-8Endocrinology & MetabolismNeurosciences1573-7365